Literature DB >> 23384821

APBB2 genetic polymorphisms are associated with severe cognitive impairment in centenarians.

Ewa Golanska1, Monika Sieruta, Sylwia M Gresner, Anna Pfeffer, Malgorzata Chodakowska-Zebrowska, Tomasz M Sobow, Izabela Klich, Malgorzata Mossakowska, Aleksandra Szybinska, Maria Barcikowska, Pawel P Liberski.   

Abstract

APBB2 gene encodes for β-amyloid precursor protein-binding family B member 2, (APBB2, FE65-like, FE65L1), an adaptor protein binding to the cytoplasmatic domain of β-amyloid precursor protein (βAPP). Over-expression of APBB2 promotes formation of β-amyloid (Aβ), the main constituent of senile plaques. Polymorphisms within APBB2 gene have been proposed as candidate risk factors for Alzheimer's disease. However, their association with longevity has never been investigated. Here we present the first attempt to analyze APBB2 polymorphisms in centenarians. We used a PCR-RFLP method to analyze two intronic nucleotide substitutions: hCV1558625 (rs17443013) and rs13133980. We found no differences in genotype or allele distribution between centenarians and young controls. After stratification of centenarians upon their cognitive performance, the APBB2 rs13133980 G allele was over-represented in centenarians with severe cognitive impairment compared to individuals without this disability. Also the hCV1558625-rs13133980 AG haplotype increased relative risk for severe cognitive impairment in centenarians. Our results support the concept of APBB2 polymorphism association with cognitive performance in the oldest age.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23384821     DOI: 10.1016/j.exger.2013.01.013

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  6 in total

1.  Arginine deprivation and immune suppression in a mouse model of Alzheimer's disease.

Authors:  Matthew J Kan; Jennifer E Lee; Joan G Wilson; Angela L Everhart; Candice M Brown; Andrew N Hoofnagle; Marilyn Jansen; Michael P Vitek; Michael D Gunn; Carol A Colton
Journal:  J Neurosci       Date:  2015-04-15       Impact factor: 6.167

2.  Unraveling the genes implicated in Alzheimer's disease.

Authors:  Mohan Giri; Abhilasha Shah; Bibhuti Upreti; Jayanti Chamling Rai
Journal:  Biomed Rep       Date:  2017-06-14

3.  Physical Activity Rewires the Human Brain against Neurodegeneration.

Authors:  Jose A Santiago; James P Quinn; Judith A Potashkin
Journal:  Int J Mol Sci       Date:  2022-06-02       Impact factor: 6.208

Review 4.  APP Protein Family Signaling at the Synapse: Insights from Intracellular APP-Binding Proteins.

Authors:  Suzanne Guénette; Paul Strecker; Stefan Kins
Journal:  Front Mol Neurosci       Date:  2017-03-30       Impact factor: 5.639

5.  Risk and protective factors of neurocognitive disorders in older adults in Central and Eastern Europe: A systematic review of population-based studies.

Authors:  Katrin Wolfova; Matej Kucera; Pavla Cermakova
Journal:  PLoS One       Date:  2021-11-30       Impact factor: 3.240

6.  A genome-wide multiphenotypic association analysis identified candidate genes and gene ontology shared by four common risky behaviors.

Authors:  Jing Ye; Li Liu; Xiaoqiao Xu; Yan Wen; Ping Li; Bolun Cheng; Shiqiang Cheng; Lu Zhang; Mei Ma; Xin Qi; Chujun Liang; Om Prakash Kafle; Cuiyan Wu; Sen Wang; Xi Wang; Yujie Ning; Xiaomeng Chu; Lin Niu; Feng Zhang
Journal:  Aging (Albany NY)       Date:  2020-02-22       Impact factor: 5.682

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.